U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07821112) titled 'Phase II Elderly/Frail Pts With Newly Diagnosed or Recurrent Malignant Glioma Tx Treated With Cesium-131 GammaTile(R)' on Sept. 09.
Brief Summary: This is a phase 2, open-label clinical trial determining feasibility, safety, and tolerability of GammaTile(R) in elderly or frail subjects with newly diagnosed or recurrent malignant gliomas.
Study Start Date: Oct., 2026
Study Type: INTERVENTIONAL
Condition:
Glioma
Glioblastoma
GBM
Glioma, Malignant
Astrocytoma
Oligodendroglioma
Elderly Glioblastoma
Elderly GBM
Intervention:
DEVICE: GammaTile(R)
GammaTile is a bioabsorbable collagen tile embedded with cesium-131 radioactive seeds...